Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA [Phase 4]
Phase 4 trial evaluating COBRA-Slim with or without fast access to TNF blockade for remission induction in early rheumatoid arthritis; resul…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
This document reports on Zimmer Biomet's Continuum Metal-on-Polyethylene hip implant post-market clinical follow-up (PMCF) study, which is c…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Exception Cementless Hip Stem
Zimmer Biomet's Exception Cementless Hip Stem clinical trial is active but not recruiting, evaluating its use for hip conditions including o…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty
This entry describes a post-market clinical follow-up (PMCF) study evaluating the safety and performance of the Zimmer Maxera Acetabular Sys…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Neurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR) [NA]
A ClinicalTrials.gov entry reports the NECTAR study evaluating neurofeedback for nociplastic pain in rheumatoid arthritis; the trial is curr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: G7 Dual Mobility With Vivacit-E or Longevity PMCF [NA]
Clinical trial update indicating Zimmer Biomet's G7 Dual Mobility hip system with Vivacit-E or Longevity PMCF is currently enrolling by invi…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Health Literacy, Rational Drug Use, and Cyberchondria in Rheumatic Diseases
A completed clinical trial evaluating health literacy, rational drug use, and cyberchondria in patients with rheumatic diseases, focusing on…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
A clinical trial update describing a study to characterize the intestinal microbiota of patients with spondyloarthritis or rheumatoid arthri…
-
FDA approval · 2025-06-13FDA Approved: HYDROXYCHLOROQUINE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for hydroxychloroquine (HYDROXYCHLOROQUINE) from Chartwell RX, LLC under an ANDA. The action upd…
-
FDA approval · 2025-06-13FDA Approved: AZATHIOPRINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for azathioprine from Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Results from a UK matched-cohort study examine the risk of venous thromboembolism among people with systemic inflammatory disorders. The tri…
-
EMA approval · 2025-06-10EMA Authorised: Jyseleca (filgotinib maleate) — Alfasigma S.p.A.
EMA authorised Jyseleca (filgotinib maleate) for rheumatoid arthritis; decision date 02/06/2025; MAH is Alfasigma S.p.A.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: The Effect of Omega-3 Fatty Acids in Patients With Rheumatoid Arthritis [NA]
A clinical trial is evaluating the effects of omega-3 fatty acids on rheumatoid arthritis. The study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis
Pfizer-sponsored trial evaluated safety and effects of tofacitinib in combination with biologic DMARDs in people with rheumatoid arthritis; …
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients
Pfizer-sponsored study evaluating predictors of response to tofacitinib in rheumatoid arthritis has completed data collection, with results …
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Named Patient Program With Certolizumab Pegol in Adults Suffering From Rheumatoid Aarthritis (RA)
This document updates a named patient program for certolizumab pegol in adults with rheumatoid arthritis, sponsored by UCB Biopharma SRL, an…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis [Phase 3]
A Phase 3 trial comparing tofacitinib with methotrexate versus upadacitinib with methotrexate for moderate to severe rheumatoid arthritis, c…
-
CLINICAL_TRIALS other · 2025-06-06Clinical Trial Update: Telitacicept for the Treatment of Refractory RA [Phase 4]
A Phase 4 clinical trial evaluating Telitacicept for refractory rheumatoid arthritis is not yet recruiting.
-
FDA approval · 2025-06-05FDA Approved: XIFYRM — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approved XIFYRM (meloxicam) under an original application by Azurity Pharmaceuticals, Inc., establishing a new branded meloxicam product…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Rheumatoid Arthritis
ProgenaBiome's pilot trial examining the role of gut flora in rheumatoid arthritis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer-sponsored trial of infliximab biosimilar 3 in rheumatoid arthritis, ulcerative colitis, Crohn's disease, and psoriasis has completed …
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Therapy of Niacin for Rheumatoid Arthritis [Phase 2]
This document reports a Phase 2 clinical trial evaluating niacin as a therapy for rheumatoid arthritis. The study is currently not yet recru…
-
CLINICAL_TRIALS other · 2025-06-04Clinical Trial Update: Insignia™ Hip Stem Outcomes Study [NA]
This document provides a status update on the Insignia Hip Stem Outcomes Study (NCT05144191) sponsored by Stryker Orthopaedics. The trial is…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Occupational and Environmental Causes of Autoimmune Diseases [NA]
A clinical trial update indicates a study examining occupational and environmental factors in autoimmune diseases has completed. Conditions …
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
This clinical trial update notes ongoing recruitment for a longitudinal follow-up study of newly diagnosed polyarthritis in children and you…